Merck & Co. Inc. stock outperforms competitors on strong trading day
This was the stock's fourth consecutive day of gains.
MRK Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Merck & Co., Inc. Securities Class Action
SAN DIEGO, CA / ACCESS Newswire / February 20, 2025 / Robbins LLP reminds stockholders that a class action was filed on ...
Microbiotica unveils data on the mechanism of action of MB310, a clinical-stage drug candidate in development for the treatment of ulcerative colitis
MB310 has been developed as an oral capsule, dosed once daily, containing a defined consortium of eight live gut commensal bacterial strains. It is designed to deliver long-term remission to UC ...
ENDPOINTS NEWS9h
Mer­ck KGaA tees up changes to lead­er­ship team; Ex-CVS Health CEO joins Ther­mo Fish­er’s board
Peter Guenter to retire as healthcare CEO, replaced by Danny Bar-Zohar; Matthias Heinzel steps down from life science unit.